Reply to Besançon et al. regarding ‘Marked improvement in HbA1c following introduction of biosimilar insulin to treatment regimen of children and youth with type 1 diabetes in Mali: A randomised controlled trial’

Ähnliche Einträge

• Marked improvement in HbA1c following introduction of biosimilar insulin to treatment regimen of children and youth with type 1 diabetes in Mali: A randomised controlled trial
  von: Stéphane Besançon, et al.
  Veröffentlicht: (2025)
• Impact of automated insulin delivery on subjective and objective sleep in children and young adults with very high HbA1c : Sleep outcomes from the CO ‐ PILOT randomised controlled trial
  von: Venus R. Michaels, et al.
  Veröffentlicht: (2025)
• Associations of adipose tissue insulin resistance with fasting blood glucose and HbA1c in adults without diabetes
  von: Ying Wei, et al.
  Veröffentlicht: (2026)
• Changes in HbA1c and diabetes‐specific quality of life following structured type 1 diabetes education: Exploratory latent profile analysis of outcomes in the DAFNE plus trial
  von: Uffe Søholm, et al.
  Veröffentlicht: (2026)
• Real‐world use of glucagon‐like peptide‐1 receptor agonists in youth with type 2 diabetes is associated with short‐term improvements in HbA1c
  von: Stephanie L. Samuels, et al.
  Veröffentlicht: (2024)